Harnessing the Power of Nutrients

Harnessing the Power of Nutrients

Share this post

Harnessing the Power of Nutrients
Harnessing the Power of Nutrients
047: Niacin, Part 2: Blood Tests, Foods, and Supplements
Mastering Nutrition

047: Niacin, Part 2: Blood Tests, Foods, and Supplements

Mastering Nutrition Episode 47

Chris Masterjohn, PhD's avatar
Chris Masterjohn, PhD
Mar 16, 2019
∙ Paid
4

Share this post

Harnessing the Power of Nutrients
Harnessing the Power of Nutrients
047: Niacin, Part 2: Blood Tests, Foods, and Supplements
Share

Introduction

In part 1 we covered what niacin is and why you need it. Here’s part 2, where Alex Leaf and I cover blood tests, foods, and supplements! 

  • How much do we need? The RDA has some flaws, including claiming women need less than men, when all the evidence shows women need *more* than men.

  • Why eating enough protein is so essential, yet so unreliable as a way of boosting niacin status.

  • How the niacin in your coffee, seeds, and grains is all locked up and unavailable, and how to release it through proper preparation. Do you drink light roast or dark roast? You may either hate or love this episode… or you might just switch coffees.

  • Should we take high-dose niacin to lower cholesterol? Alex has a theory on how we can do that without getting diabetes. 😬

  • High-dose niacin can cause liver failure and can kill lab mice. But Alex and I know how to steer clear of that problem!

  • NAD-boosting supplements are the new darling of the anti-aging industry. But should we take nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), or should we endure all the whole-body burning 🔥 that the folks injecting NAD+ are so hyped up about? We discuss the promises and problems of these approaches.

  • Why you should match glycine to one form of niacin and trimethylglycine (TMG) to all of them.

Show Notes

00:38 Cliff Notes

01:35 Recap of Part 1

09:33 Markers of niacin status

11:34 Methylated metabolites of niacin in the urine as a marker of niacin status

13:07 Caveat to using methylated metabolites of niacin in the urine as a marker of niacin status

14:17 Erythrocyte NAD(H)/NADP(H) ratio, the “niacin number,” as a marker of niacin status

16:57 Caveat to the niacin number as a marker of niacin status

22:35 Critique on how the RDA for niacin was established

34:14 How protein intake affects the dietary requirement for preformed niacin

36:50 Estrogen regulates the synthesis of niacin from tryptophan.

37:37 In men in particular, niacin synthesis from tryptophan might just be a way to clear excess tryptophan.

39:33 General discussion about protein requirements

43:47 How different forms of food processing, such as nixtamalization, fermentation, and sprouting, increase the bioavailability of niacin

46:53 Niacin in coffee

47:54 Niacin in nutritional yeast

48:18 Dietary sources of niacin, divided into five tiers

53:59 Niacin in herbs and spices, including spirulina

57:48 The contribution of the microbiome to niacin status is not well studied.

58:58 Where we would expect to see niacin deficiency 

59:40 Risk factors for niacin deficiency include Hartnup’s disease, megaduodenum, intestinal malabsorption, carcinoid tumors, certain drugs, alcoholism, HIV/AIDS, and deficiencies of iron, riboflavin, and B6.

01:03:54 Risk factors for suboptimal niacin status include a diet based on unprocessed whole grains, a diet based on sugar and fat, a diet low in non-collagen protein, any form of cellular damage, and low ATP levels.

01:08:44 How metformin and berberine could affect niacin status

01:11:30 The effect of leucine and muscle growth on niacin status

01:13:55 The prevalence of inadequate niacin intake and niacin deficiency

01:18:02 Contributors to niacin toxicity

01:19:09 The use of nicotinic acid to benefit blood lipids and reduce heart disease risk

01:25:16 Potential side effects of taking nicotinic acid to manage blood lipids include the flushing reaction, liver harm, and increased diabetes risk.

01:28:23 The mechanism behind high-dose nicotinic acid-induced insulin resistance and how you could mitigate it

01:42:02 Rodent studies of nicotinamide riboside supplementation 

01:44:58 Human studies of nicotinamide riboside supplementation

01:50:34 Why the rodent studies of nicotinamide riboside supplementation look more promising than the human studies

01:58:17 What is the probability that someone would get longevity benefits from supplementing with nicotinamide riboside?

01:59:16 Whether or not Alex and Chris will start supplementing with niacin after doing the research for this podcast

02:00:16 Should someone with hypercholesterolemia consider taking nicotinic acid? How should they manage the side effects, and which form is best?

02:04:54 Does it matter if niacin is taken with food?

Niacin Links and Research

Yvan-Charvet L, Kling J, Pagler T, Li H, Hubbard B, Fisher T, Sparrow CP, Taggart AK, Tall AR. Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib. Arterioscler Thromb Vasc Biol [Internet]. 2010 Jul;30(7):1430–1438. Available from: http://dx.doi.org/10.1161/ATVBAHA.110.207142 PMCID: PMC2917780

Khera AV, Patel PJ, Reilly MP, Rader DJ. The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality. J Am Coll Cardiol [Internet]. 2013 Nov 12;62(20):1909–1910. Available from: http://dx.doi.org/10.1016/j.jacc.2013.07.025  PMID: 23933538

Kamanna VS, Ganji SH, Kashyap ML. Recent advances in niacin and lipid metabolism. Curr Opin Lipidol [Internet]. 2013 Jun;24(3):239–245. Available from: http://dx.doi.org/10.1097/MOL.0b013e3283613a68   PMID: 23619367

Garg A, Sharma A, Krishnamoorthy P, Garg J, Virmani D, Sharma T, Stefanini G, Kostis JB, Mukherjee D, Sikorskaya E. Role of Niacin in Current Clinical Practice: A Systematic Review. Am J Med [Internet]. 2017 Feb;130(2):173–187. Available from: http://dx.doi.org/10.1016/j.amjmed.2016.07.038  PMID: 27793642

Wang W, Basinger A, Neese RA, Christiansen M, Hellerstein MK. Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women. Am J Physiol Endocrinol Metab [Internet]. 2000 Jul;279(1):E50–9. Available from: http://dx.doi.org/10.1152/ajpendo.2000.279.1.E50  PMID: 10893322

Goldie C, Taylor AJ, Nguyen P, McCoy C, Zhao X-Q, Preiss D. Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials. Heart [Internet]. 2016 Feb;102(3):198–203. Available from: http://dx.doi.org/10.1136/heartjnl-2015-308055  PMCID: PMC4752613

Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, Connolly DT. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol [Internet]. 2006 Dec;126(12):2637–2646. Available from: http://dx.doi.org/10.1038/sj.jid.5700586  PMID: 17008871

Hanson J, Gille A, Zwykiel S, Lukasova M, Clausen BE, Ahmed K, Tunaru S, Wirth A, Offermanns S. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. J Clin Invest [Internet]. 2010 Aug;120(8):2910–2919. Available from: http://dx.doi.org/10.1172/JCI42273  PMCID: PMC2912194

Dunbar RL, Gelfand JM. Seeing red: flushing out instigators of niacin-associated skin toxicity. J Clin Invest [Internet]. 2010 Aug;120(8):2651–2655. Available from: http://dx.doi.org/10.1172/JCI44098  PMCID: PMC2912206

Stern RH, Spence JD, Freeman DJ, Parbtani A. Tolerance to nicotinic acid flushing. Clin Pharmacol Ther [Internet]. 1991 Jul;50(1):66–70. Available from: https://www.ncbi.nlm.nih.gov/pubmed/1855354  PMID: 1855354

Stern RH, Freeman D, Spence JD. Differences in metabolism of time-release and unmodified nicotinic acid: explanation of the differences in hypolipidemic action? Metabolism [Internet]. 1992 Aug;41(8):879–881. Available from: https://www.ncbi.nlm.nih.gov/pubmed/1640866  PMID: 1640866

Kourtzidis IA, Dolopikou CF, Tsiftsis AN, Margaritelis NV, Theodorou AA, Zervos IA, Tsantarliotou MP, Veskoukis AS, Vrabas IS, Paschalis V, Kyparos A, Nikolaidis MG. Nicotinamide riboside supplementation dysregulates redox and energy metabolism in rats: Implications for exercise performance. Exp Physiol [Internet]. 2018 Oct;103(10):1357–1366. Available from: http://dx.doi.org/10.1113/EP086964  PMID: 30007015

Piepho RW. The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol. Am J Cardiol [Internet]. 2000 Dec 21;86(12A):35L–40L. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11374854  PMID: 11374854

Poddar SK, Sifat AE, Haque S, Nahid NA, Chowdhury S, Mehedi I. Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule. Biomolecules [Internet]. 2019 Jan 21;9(1). Available from: http://dx.doi.org/10.3390/biom9010034  PMCID: PMC6359187

Fricker RA, Green EL, Jenkins SI, Griffin SM. The Influence of Nicotinamide on Health and Disease in the Central Nervous System. Int J Tryptophan Res [Internet]. 2018 May 21;11:1178646918776658. Available from: http://dx.doi.org/10.1177/1178646918776658  PMCID: PMC5966847

Chi Y, Sauve AA. Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection. Curr Opin Clin Nutr Metab Care [Internet]. 2013 Nov;16(6):657–661. Available from: http://dx.doi.org/10.1097/MCO.0b013e32836510c0  PMID: 24071780

Dollerup OL, Christensen B, Svart M, Schmidt MS, Sulek K, Ringgaard S, Stødkilde-Jørgensen H, Møller N, Brenner C, Treebak JT, Jessen N. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr [Internet]. 2018 Aug 1;108(2):343–353. Available from: http://dx.doi.org/10.1093/ajcn/nqy132  PMID: 29992272

Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun [Internet]. 2018 Mar 29;9(1):1286. Available from: http://dx.doi.org/10.1038/s41467-018-03421-7  PMCID: PMC5876407

Airhart SE, Shireman LM, Risler LJ, Anderson GD, Nagana Gowda GA, Raftery D, Tian R, Shen DD, O’Brien KD. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLoS One [Internet]. 2017 Dec 6;12(12):e0186459. Available from: http://dx.doi.org/10.1371/journal.pone.0186459  PMCID: PMC5718430

Morgan JM, Capuzzi DM, Guyton JR. A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. Am J Cardiol [Internet]. 1998 Dec 17;82(12A):29U–34U; discussion 39U–41U. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9915660  PMID: 9915660

Keenan JM. Wax-matrix extended-release niacin vs inositol hexanicotinate: a comparison of wax-matrix, extended-release niacin to inositol hexanicotinate “no-flush” niacin in persons with mild to moderate dyslipidemia. J Clin Lipidol [Internet]. 2013 Jan;7(1):14–23. Available from: http://dx.doi.org/10.1016/j.jacl.2012.10.004  PMID: 23351578

Soudijn W, van Wijngaarden I, Ijzerman AP. Nicotinic acid receptor subtypes and their ligands. Med Res Rev [Internet]. 2007 May;27(3):417–433. Available from: http://dx.doi.org/10.1002/med.20102  PMID: 17238156

Ellinger P, Kader MM. Nicotinamide metabolism in mammals. Biochem J [Internet]. 1949;44(1):77–87. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16748483  PMCID: PMC1274811

Stratford MR, Dennis MF, Hoskin P, Phillips H, Hodgkiss RJ, Rojas A. Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoring. Br J Cancer [Internet]. 1996 Jul;74(1):16–21. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8679452  PMCID: PMC2074616

Dragovic J, Kim SH, Brown SL, Kim JH. Nicotinamide pharmacokinetics in patients. Radiother Oncol [Internet]. 1995 Sep;36(3):225–228. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8532910  PMID: 8532910

McKenney JM, Proctor JD, Harris S, Chinchili VM. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. JAMA [Internet]. 1994 Mar 2;271(9):672–677. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8309029  PMID: 8309029

Pieper JA. Understanding niacin formulations. Am J Manag Care [Internet]. 2002 Sep;8(12 Suppl):S308–14. Available from: https://www.ncbi.nlm.nih.gov/pubmed/12240702  PMID: 12240702

Wallace TC, McBurney M, Fulgoni VL 3rd. Multivitamin/mineral supplement contribution to micronutrient intakes in the United States, 2007-2010. J Am Coll Nutr [Internet]. 2014;33(2):94–102. Available from: http://dx.doi.org/10.1080/07315724.2013.846806  PMID: 24724766

Moreschi I, Bruzzone S, Nicholas RA, Fruscione F, Sturla L, Benvenuto F, Usai C, Meis S, Kassack MU, Zocchi E, De Flora A. Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J Biol Chem [Internet]. 2006 Oct 20;281(42):31419–31429. Available from: http://dx.doi.org/10.1074/jbc.M606625200  PMID: 16926152

Airhart SE, Shireman LM, Risler LJ, Anderson GD, Nagana Gowda GA, Raftery D, Tian R, Shen DD, O’Brien KD. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLoS One [Internet]. journals.plos.org; 2017 Dec 6;12(12):e0186459. Available from: http://dx.doi.org/10.1371/journal.pone.0186459  PMCID: PMC5718430

Jacobson EL, Jacobson MK. [19] Tissue NAD as a biochemical measure of niacin status in humans. Methods in Enzymology [Internet]. Academic Press; 1997. p. 221–230. Available from: http://www.sciencedirect.com/science/article/pii/S0076687997801139 

Jacobson EL, Jacobson MK. Biochemical method to measure niacin status in a biological sample [Internet]. US Patent. 6287796, 2001 [cited 2019 Feb 16]. Available from: https://patentimages.storage.googleapis.com/19/41/2d/a1de97bc17d927/US6287796.pdf 

Fu CS, Swendseid ME, Jacob RA, McKee RW. Biochemical markers for assessment of niacin status in young men: levels of erythrocyte niacin coenzymes and plasma tryptophan. J Nutr [Internet]. academic.oup.com; 1989 Dec;119(12):1949–1955. Available from: http://dx.doi.org/10.1093/jn/119.12.1949  PMID: 2621487

Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids : Health and Medicine Division [Internet]. [cited 2019 Feb 16]. Available from: http://www.nationalacademies.org/hmd/Reports/2002/Dietary-Reference-Intakes-for-Energy-Carbohydrate-Fiber-Fat-Fatty-Acids-Cholesterol-Protein-and-Amino-Acids.aspx 

Dölle C, Skoge RH, Vanlinden MR, Ziegler M. NAD biosynthesis in humans--enzymes, metabolites and therapeutic aspects. Curr Top Med Chem [Internet]. ingentaconnect.com; 2013;13(23):2907–2917. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24171775  PMID: 24171775

Clegg KM. BOUND NICOTINIC ACID IN DIETARY WHEATEN PRODUCTS. Br J Nutr [Internet]. cambridge.org; 1963;17:325–329. Available from: https://www.ncbi.nlm.nih.gov/pubmed/14045335  PMID: 14045335

Adrian J, Frangne R. Synthesis and availability of niacin in roasted coffee. Adv Exp Med Biol [Internet]. Springer; 1991;289:49–59. Available from: https://www.ncbi.nlm.nih.gov/pubmed/1897406  PMID: 1897406

Frederick DW, Loro E, Liu L, Davila A Jr, Chellappa K, Silverman IM, Quinn WJ 3rd, Gosai SJ, Tichy ED, Davis JG, Mourkioti F, Gregory BD, Dellinger RW, Redpath P, Migaud ME, Nakamaru-Ogiso E, Rabinowitz JD, Khurana TS, Baur JA. Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle. Cell Metab [Internet]. 2016 Aug 9;24(2):269–282. Available from: http://dx.doi.org/10.1016/j.cmet.2016.07.005  PMCID: PMC4985182

Liu L, Su X, Quinn WJ 3rd, Hui S, Krukenberg K, Frederick DW, Redpath P, Zhan L, Chellappa K, White E, Migaud M, Mitchison TJ, Baur JA, Rabinowitz JD. Quantitative Analysis of NAD Synthesis-Breakdown Fluxes. Cell Metab [Internet]. 2018 May 1;27(5):1067–1080.e5. Available from: http://dx.doi.org/10.1016/j.cmet.2018.03.018  PMCID: PMC5932087

Creeke PI, Dibari F, Cheung E, van den Briel T, Kyroussis E, Seal AJ. Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra. J Nutr [Internet]. academic.oup.com; 2007 Sep;137(9):2013–2017. Available from: http://dx.doi.org/10.1093/jn/137.9.2013  PMID: 17709435

Strohm D, Bechthold A, Isik N, Leschik-Bonnet E, Heseker H. Revised reference values for the intake of thiamin (vitamin B1), riboflavin (vitamin B2), and niacin. NFS Journal [Internet]. Elsevier; 2016 Aug 1;3:20–24. Available from: http://www.sciencedirect.com/science/article/pii/S2352364615300432 

Pissios P. Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme. Trends Endocrinol Metab [Internet]. 2017 May;28(5):340–353. Available from: http://dx.doi.org/10.1016/j.tem.2017.02.004  PMCID: PMC5446048

Ongol MP, Niyonzima E, Gisanura I, Vasanthakaalam H, Others. Effect of germination and fermentation on nutrients in maize flour. Pakistan Journal of Food Sciences [Internet]. Pakistan Society of Food Scientists and Technologists; 2013;23(4):183–188. Available from: https://www.researchgate.net/profile/Niyonzima_Eugene2/publication/281554021_Effect_of_germination_and_fermentation_on_nutrients_in_maize_flour/links/55ed7ecd08ae21d099c759db.pdf 

Carpenter KJ. The relationship of pellagra to corn and the low availability of niacin in cereals. Experientia Suppl [Internet]. Springer; 1983;44:197–222. Available from: https://www.ncbi.nlm.nih.gov/pubmed/6357846  PMID: 6357846

Ghosh HP, Sarkar PK, Guha BC. Distribution of the Bound Form of Nicotinic Acid in Natural Materials. J Nutr [Internet]. Oxford University Press; 1963 Apr 1 [cited 2019 Feb 14];79(4):451–453. Available from: https://academic.oup.com/jn/article-abstract/79/4/451/4779288 

Lerner F, Niere M, Ludwig A, Ziegler M. Structural and functional characterization of human NAD kinase. Biochem Biophys Res Commun [Internet]. 2001 Oct 19;288(1):69–74. Available from: http://dx.doi.org/10.1006/bbrc.2001.5735  PMID: 11594753

Sorci L, Cimadamore F, Scotti S, Petrelli R, Cappellacci L, Franchetti P, Orsomando G, Magni G. Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis. Biochemistry [Internet]. 2007 Apr 24;46(16):4912–4922. Available from: http://dx.doi.org/10.1021/bi6023379  PMID: 17402747

Heimburger DC. Clinical Manifestations of Nutrient Deficiencies and Toxicities. In: Ross AC, editor. Modern Nutrition in Health and Disease [Internet]. Available from: https://chrismasterjohnphd.com/textbook 

Kirkland JB. Niacin. In: Ross AC, editor. Modern Nutrition in Health and Disease [Internet]. Available from: https://chrismasterjohnphd.com/textbook 

Niacin [Internet]. Linus Pauling Institute. 2014 [cited 2019 Feb 14]. Available from: https://lpi.oregonstate.edu/mic/vitamins/niacin 

Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, its Panel on Folate, Vitamins OB, Choline. Niacin [Internet]. National Academies Press (US); 1998 [cited 2019 Feb 14]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK114304/ 

Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, its Panel on Folate, Vitamins OB, Choline. Riboflavin [Internet]. National Academies Press (US); 1998 [cited 2019 Feb 14]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK114322/ 

Read the Transcript or Leave a Comment

Masterpass members have access to the transcript below.

Masterpass members can also read and leave comments below. Non-members can read and leave comments on the general podcast page.

Learn more about the Masterpass here.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Chris Masterjohn, PhD
Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share